Icon (ICLR) Shares Outstanding (2009 - 2026)
Icon's (ICLR) quarterly Shares Outstanding (Entity) came in at $76.6 million in Q4 2025, down 5.19% year-over-year from $80.8 million in Q4 2024, and down 5.19% quarter-over-quarter from $80.8 million in Q4 2024.
Analysis
Icon (ICLR) Shares Outstanding (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Shares Outstanding (Entity) for 17 consecutive years, with $76.6 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) fell 5.19% year-over-year to $76.6 million in Q4 2025; TTM through Dec 2025 was $76.6 million, a 5.19% decrease from a year earlier, with the FY2025 full-year figure at $76.6 million, down 5.19% from the prior year.
- Shares Outstanding (Entity) was $76.6 million for Q4 2025 at Icon, down from $80.8 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $82.5 million in Q4 2023 and troughed at $67.1 million in Q4 2021.
- A 5-year average of $77.7 million and a median of $80.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) rose 27.13% in 2021 and dropped 5.19% in 2025, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $67.1 million in 2021, then increased by 21.78% to $81.7 million in 2022, then increased by 0.94% to $82.5 million in 2023, then slipped by 2.11% to $80.8 million in 2024, then dropped by 5.19% to $76.6 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $76.6 million (Q4 2025), $80.8 million (Q4 2024), and $82.5 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 166.10 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 28.17 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 78.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 48.02 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 94.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 355.16 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 62.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 13.90 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 46.38 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.42 Mn |
| Mar 31, 2026 | 78.42 Mn |
| Dec 31, 2025 | 78.42 Mn |
| Sep 30, 2025 | 82.48 Mn |
| Jun 30, 2025 | 82.48 Mn |
| Mar 31, 2025 | 82.48 Mn |
| Dec 31, 2024 | 82.48 Mn |
| Sep 30, 2024 | 82.10 Mn |
| Jun 30, 2024 | 82.10 Mn |
| Mar 31, 2024 | 82.10 Mn |
| Dec 31, 2023 | 82.10 Mn |
| Sep 30, 2023 | 81.53 Mn |
| Jun 30, 2023 | 81.53 Mn |
| Mar 31, 2023 | 81.53 Mn |
| Dec 31, 2022 | 81.53 Mn |
| Sep 30, 2022 | 67.11 Mn |
| Jun 30, 2022 | 67.11 Mn |
| Mar 31, 2022 | 67.11 Mn |
| Dec 31, 2021 | 67.11 Mn |
| Sep 30, 2021 | 52.86 Mn |